LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy

Name: LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy
Published: 2012
License: Public Domain

Boehringer Ingelheim · 2012

ClinicalTrials.gov · Datasets · License: Public Domain · 2012

Open Source ↗

carcinoma

carcinoma, non-small-cell lung, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy

Related documents